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Measurement of the vascular access flow rate (Qa) is a widely
accepted method for surveillance and predicting access
failure. Among current practical methods, the ultrasound
dilution technique is standard, but this requires a costly
device available in few hemodialysis (HD) centers. Here, we
devised a simple hemoglobin dilution technique to
accurately measure Qa without the need for any special
machines. Before HD, values of Qa were determined in each
of 30 patients by hemoglobin dilution and then, in the same
session, by ultrasound dilution. There was a significant
correlation between the two techniques using automated
hemoglobin and hematocrit or centrifuge-measured
hematocrit levels to calculate HD fluid-derived Qa values. Our
study shows that the HD dilution technique, using no special
device, is economical, highly accurate, and easy to perform,
and can be used as an alternative to standard ultrasound
dilution for vascular access surveillance.
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A well-functioning vascular access is crucial in achieving
adequacy of hemodialysis (HD).1 Failure to detect access
dysfunction increases consequences on morbidity and mor-
tality. Regular measurement of the vascular access flow rate
(Qa) is the most widely accepted method for surveillance and
predicting access failure.2 At present, various indicator dilution
techniques are widely used in determining Qa during HD.
2–7
The most extensive validation as well as the most precise
standardization is ultrasound dilution technique (UDT).6–10
The indicator used in the UDT is normal saline, whereas the
detector is an ultrasound dilution sensor (Figure 1a). Thus, the
UDT requires a specific instrument that is available in limited
HD centers.
To overcome the limitations of UDT, a novel simple
method for measuring the Qa is created, and this is based on
a red blood cell (RBC) concentration dilution principle. In
this novel hemoglobin (Hb) dilution technique (HDT), only
the standard HD machine and routine HD materials are
required. To determine the Qa by the HDT, the HD circuit
had also been reversed (Figures 1b and 2) as in the UDT. In
the HDT, only two samples of either Hb or Hct at the
baseline before beginning HD session and 12 seconds after
starting blood pump for infusion of the priming saline in the
reverse manner are used for calculating the Qa.
This study was conducted to analyze the correlation
between the values of Qa measured by the HDT, using
automated Hb (Hba), automated Hct (Hcta), or manual
centrifuged Hct (Hctm), and those determined by the
standard UDT in the same HD session.
RESULTS
Demographic and baseline laboratory data
Of the 30 participating patients, there were 12 male and 18
female subjects who underwent thrice-a-week high flux HD
for 4.2±3.1 years. All patients were nonsmokers and had no
significant residual renal function with daily urine output
below 100 ml day1. The mean values of the patients’ age and
dry weights were 58.7±14.4 years and 55.4±11.9 kg,
respectively. The types of vascular access were native
arteriovenous fistula (AVF) and loop graft (AVG) in 20 (all
at forearm) and 10 (all at forearm) participating patients,
respectively (Table 1).
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The mean arterial blood pressure values before measuring
Qa were not different between the HDT and the UDT
(100.2±8.6 vs 97.1±10.5 mm Hg, NS).
Vascular access flow rate
The values of standard UDT-derived Qa were derived from
the average of the duplicated measurement, which demons-
trated a good repeatability (coefficient of variation¼ 6.4%).
To test the repeatability of the HDT-derived Qa values, the
second measurement using the remaining priming saline in
the blood line was consequently repeated at 1 min after the
first one in the same session. The coefficient of variation of
these repeated measurements were 8.3, 6.9, and 9.7% for the
HDT-derived Qa values using Hba, Hcta, and Hctm,
respectively, all of which represented the good repeatability.
The values of standard UDT-derived Qa were
886.50±439.17 ml min1 and were utilized as the reference
values. The values of Qa determined by the HDT, calculated
by using the RBC concentration (Hba, Hcta, and Hctm), are
demonstrated in Table 2. In all 30 patients, there were no
significant differences in the mean values of the standard
UDT-derived Qa and HDT-derived Qa using any RBC
concentrations, Hba (924.06±415.31 ml min
1, NS), Hcta
(983.51±512.68 ml min1, NS), or Hctm (954.86±
431.81 ml min1, NS). Importantly, they were highly sig-
nificantly correlated with the values of UDT (all, r40.90,
Po0.01) (Table 2). The HDT determined by Hba had the
lowest mean absolute difference (37.56±147.25 ml min1)
and the highest significant correlation (r¼ 0.94, Po0.01).
This trend was also shown in both subgroups of AVF
(r¼ 0.93, 0.92, and 0.89 for HDT-derived Qa using Hba, Hcta,
and Hctm, respectively) and AVG patients (r¼ 0.98, 0.95, and
0.90 for HDT-derived Qa using Hba, Hcta, and Hctm,
respectively). Moreover, the better correlations were shown
in the AVG than the AVF subgroups. By regression analysis,
Figure 3 shows the correlation between the values of Qa from
the HD01 UDT and all three HDT methods. The regression
equation of the HDT using Hba, which provides the highest
correlation was UDTQa¼ [1.00HDT(Hba)Qa]34.10.
A Bland–Altman plot comparing the HDT using Hba and
UDT is displayed in Figure 4.
DISCUSSION
This study demonstrated the novel ‘Hemoglobin Dilution
Technique (HDT)’ for measuring vascular access flow rate
(Qa). The HDT using any RBC concentration values for
calculation could provide an excellent correlation and
minimal mean absolute difference with the standard UDT
method (Table 2). Among all HDT methods, the Hba-derived
Qa showed the best correlation and the lowest mean absolute
difference when compared with the standard UDT (Table 2,
Figure 4). This might be explained by the high accuracy of
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Figure 1 | HD circuit during vascular access flow rate
measurement by the transonic HD01 machine. The HD circuit was
reversed and arterial/venous line sensors were placed as picture.
Vascular access
~
 Qs
Dialyzer
Qa
Qs
Qa + Qs
Needle ANeedle V
Blood line ABlood line V
NSS
BFR
Hv 
Vascular access
QaQa
Needle ANeedle V
Ha
Figure 2 | Step by step during vascular access flow rate
measurement by the novel HDT. (a) The first blood sample was
withdrawn from the arterial AVF needle (needle A) for Ha
determination. (b) Connection between needles A and V and blood
lines A and V was set in a reversed position. Then, the blood pump
was started at 300 ml min1 (BFR). The second blood sample was
taken from the sample port of the arterial blood line (blood line A) for
Hv determination. Ha¼ hemoglobin or hematocrit in vascular access,
before saline dilution; Hv ¼ hemoglobin or hematocrit in vascular
access, after saline dilution; Qa ¼ vascular access flow rate, Qs ¼ saline
infusion flow or adjusted pump flow (ml min1)¼ [1(BFR200)/
2000] BFR; BFR¼blood pump setting flow rate (ml min1),
NSS¼ normal saline preprimed in the HD circuit at the initial setup.
Table 1 | Demographic data
Total (30 patients) AVF (20 patients) AVG (10 patients)
Range Mean±s.d. Range Mean±s.d. Range Mean±s.d.
Age (years) 34–93 58.7±14.4 34–81 55.6±12.5 38–93 64.8±16.8
Duration of hemodialysis (years) 0.3–11.0 4.2±3.1 0.6–9.4 4.9±4.5 0.3–11.0 2.9±3.3
Dry weight (kg) 38–81 55.4±11.9 38–81 57.9±12.2 38–70 50.5±10.1
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directed determination of RBC concentration by Hba than
both Hcta, which was derived from the calculation, and Hctm.
However, the Hctm-derived Qa, which also provided a good
correlation, could be a reliable alternative to Hba-derived Qa
in the situation that Hctm is more practical to determine than
the automated values.
The HDT is a dilution method based on saline infusion
into vascular access via the arterial needle to create
hemodilution and determination of two Hb (or Hct) values,
the basal one before saline infusion and the other during
saline infusion. Using isotonic saline injection to cause
hemodilution is advantageous in that it is safe, available, and
easy to mix with blood. The priming saline in HDT also
offers several additional benefits, and these included the
following: the exact saline flow rate can be known without
any blood mixing; there is no need for additional infusion
materials; and there is no change in blood volume because of
simultaneous arterial and venous blood line connection. This
HDT is simple to set up and can be used in all HD centers.
Both are superior advantages when compared to other
previously reported hemodilution techniques, all of which
required special sensor to detect the changes in hematocrit.5
In this study, all pitfalls of indicator dilution method were
considerably prevented. Ultrafiltration was kept off during
the measurement by both HDT and UDT to ensure that the
blood flow is identical in the circuit. The duration of saline
infusion in HDT was set at 12 s to avoid the presence of
cardiopulmonary recirculation and to allow the complete
mixing with blood. The insertion of the venous or return
needle in the direction opposite to access flow, placing the
two needles at least 3 cm apart and setting blood pump
setting flow rate (BFR) at 300 ml min1, also facilitated
mixing, as Qa is influenced by blood pressure, which usually
falls during HD. This error was minimized by performing
this HDT before the start of dialysis session, and there was no
change in blood volume due to simultaneous arterial and
venous blood line connection. Also, the standard UDT was
conducted as early as possible, during the first 60 min of
dialysis session.
The countercurrent peristaltic flow, created by the blood
pump in the reversal blood line position, may potentially
decrease the Qa in both methods. Indeed, the rapid injection
of saline into the vascular access in UDT may cause
substantial increase in the saline injection flow that could
reduce the Qa more than saline infusion in HDT. This may
partially explain the higher mean values of Qa in HDT
Table 2 | Vascular access flow rates determined by the UDT
and the HDT
Method Mean±s.d. (ml min1) r
Mean absolute
difference±s.d.
(ml min1)
UDT 886.50±439.17
HDT
Using Hba 924.06±415.31
a 0.94b 37.56±147.25
Using Hcta 983.51±512.68
a 0.93b 97.01±191.42
Using Hctm 954.86±431.81
a 0.91b 68.36±190.45
AVF, arteriovenous fistula; AVG, arteriovenous graft; Hb, hemoglobin; Hct,
hematocrit; r, correlation from linear regression analysis.
aNot significantly different (P40.05) with UDT values from paired Student’s t-test.
bSignificant correlation (Po0.01) with UDT values from linear regression analysis. 0
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Figure 3 | Correlation between the transonic HD01 UDT and
the HDT. (a) Automated Hb, (b) automated Hct, and
(c) manual centrifuged Hct.
1084 Kidney International (2008) 73, 1082–1086
t e c h n i c a l n o t e s K Tiranathanagul et al.: Measurement of vascular access flow rate by HDT
(Table 2). Alternatively, the earlier measurement by HDT
might possibly be less affected by the decrease in blood
pressure when compared with UDT.
There are several other practical methods to determine the
Qa, including the thermodilution
11 and conductivity/ionic
dialysance method;12,13 however, both are time consuming
and require special function in the dialysis machine. Recently,
the temperature gradient method14 was introduced. This
interesting method was not as much time consuming as the
original thermodilution technique, but the HD machine with
additional blood temperature monitoring configuration was
required. The glucose pump infusion technique, which does
not require any special devices, also needs the specific
procedure setup.15,16
In conclusion, the HDT, using no special device, is highly
accurate, easy to perform, and economical. This maneuver
could be routinely used to measure and follow the vascular
access flow in a surveillance protocol as a reliable alternative
to the ultrasound dilution method.
MATERIALS AND METHODS
Patients
The HDT in measuring Qa was conducted in 30 end-stage renal
disease patients who, for at least 3 months, underwent thrice-a-week
high flux HD, using Fresenius 4008 HD machine, blood pump flow
rate of which was regularly calibrated. All patients were more than
18 years and had no severe cardiovascular diseases. The study was
approved by the Ethics Committee of the Faculty of Medicine,
Chulalongkorn University Hospital, Bangkok, Thailand. Informed
consent was obtained from each patient.
Technique
Ultrasound dilution technique. The gold standard values of the
Qa were determined by the standard UDT using HD01 device
(Transonic System Inc., Ithaca, New York, USA) as previously
described.4,9 The values of Qa were derived from the average of the
duplicated measurement during the first 60 min of dialysis session
according to the manufacturer’s recommendation. As illustrated in
Figure 1a, the direction of the blood flow in the HD circuit had to be
reversed. The blood pump was rolled at 300 ml min1 without
ultrafiltration. The indicator, sterile isotonic saline, was injected into
the venous bubble trap before ultrasound dilution sensor, mixed
with the blood flow in the extracorporeal circuit (Qb), then passed
to the arterial access, and was detected by arterial sensor.10 These
duplicated measurement was also analyzed for the repeatability.
Novel HDT. To determine the Qa by the HDT, only two samples
of either Hb or Hct at the baseline before beginning of HD session
and at 12 s after infusion of priming saline using the blood pump in
the reverse manner (Figure 2b) were required. When the regular
blood circulation circuit was filled with priming saline and the
vascular access was cannulated with arterial (needle A) and venous
(needle V) AV access needles, the first blood sample (Ha) was
collected from needle A (Figure 2a) for determination of Hb or Hct.
Then, the needles A and V were connected in a reversed position with
the venous blood line (blood line V) and the arterial blood line
(blood line A), respectively (Figure 2b). The BFR was set up at
300 ml min1 and ultrafiltration rate was set up at zero. Twelve
seconds after the blood pump was started and the priming saline in
the blood line was constantly infused into the upstream of the AV
access, the second downstream blood sample (Hv) was taken from
the sampling port of the arterial blood line (Figure 2b) and was also
determined for the values of Hb or Hct. Indeed, the actually effective
Qs was not the same as the set-up BFR value of 300 ml min
1 because
blood lines reduce the stroke volume from prepump negative
pressure.17 The values could be obtained from the formula.17
Qs ¼ ½1  ðBFR  200Þ=2000BFR
To test the repeatability of this HDT, the repeated measurement was
determined consequently after the first one. After the second blood
sample was drawn in the first Qa measurement, the blood pump was
stopped for 30 s to allow the saline to completely mix with the blood
in the body. Then, the second Qa measurement was performed in the
same manner as the first one and was started by collecting the first
blood sample (Ha) from needle A, which was temporally dis-
connected from the blood line. The second blood sample was taken
from the sampling port of the arterial blood line after 12 s of infusion
of the remaining priming saline left over in the blood line at the
300 ml min1 setting rate.
At the end of the test procedures, the blood lines A and B were
reconnected in the regular nonreversed position.
By the basis of RBC balance,16 thus
Qa  Ha ¼ ðQa þ QsÞ  Hv
¼ Qa  Hv þ Qs  Hv
Qa  ðHa  HvÞ ¼ Qs  Hv
Qa ¼ Qs  Hv
Ha  Hv
Where; Qa ¼ vascular access blood flow ðml= minÞ
Qs ¼ effective saline flow rate ðml= minÞ
¼ ½1  ðBFR  200Þ=2000BFR
BFR ¼ blood pump flow rate ðml= minÞ
Ha ¼ Hb or Hct in the access flow before saline infusion
Hv ¼ Hb or Hct in the access flow twelve seconds after
starting saline infusion
This study was conducted to analyze the correlation between the
values of Qa measured by this novel HDT, using Hba, Hcta, or Hctm,
and those determined by the standard UDT in the same HD session.
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Figure 4 | Bland–Altman HDT (Hba)/UDT. Qa¼ vascular access flow
rate; HDT (Hba)¼ hemoglobin dilution technique using automated
hemoglobin; UDT¼ transonic HD01 UDT.
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The values of Hba and Hcta were measured by the automated
complete blood count analysis in the hospital’s central laboratory
using automated Bayer Advia 120 hematology analyzer (Bayer
Diagnostics, Tarrytown, NY, USA). The Hctm levels were determined
by manual centrifugation technique at 10 000 r.p.m. for 5 min. The
processes took about 30 min after the sample collection for
automated method and 10 min for manual centrifugation method
to receive the results for HDT-derived Qa calculation.
Study design
The values of Qa in each participating patient were determined
before the start of HD session by the novel HDT and then during the
first 60 min of the same dialysis session, by the standard UDT.
Statistical analysis
All data were expressed as mean±s.d. The data from UDT and HDT
were compared by the paired Student’s t-test, whereas the relation-
ship between them was obtained by Pearson correlation and linear
regression analysis. The Bland–Altman plot was used to visually
assess agreement between the different methods. The repeatability of
duplicated measurements is shown as the coefficient of variation for
UDT and HDT. The statistical significance was defined when
Po0.05.
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